Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysisn from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial

摘要

Objectives. Documentation on secondary prevention with statins in RA patients with coronary heart disease (CHD) is limited, despite the increased risk of CHD in RA. Our objective was to describe the effect of statin treatment on lipid levels and cardiovascular disease (CVD) events in patients with RA who participated in the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) study.